New hepatitis b drug enters human testing phase
Disease control
Recruiting now
This early-stage trial is testing a new drug called Tune-401 in adults with chronic hepatitis B. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure how it affects the hepatitis B virus in participants who are already taking …
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC